We are live on ! Find out more
GLSI icon

Greenwich LifeSciences
GLSI

51 hedge funds and large institutions have $11.2M invested in Greenwich LifeSciences in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

11% more funds holding

Funds holding: 46 → 51 (+5)

1% more capital invested

Capital invested by funds: $11.1M → $11.2M (+$87K)

0.38% more ownership

Funds ownership: 8.84% → 9.21% (+0.38%)

Holders
51
Holders Change
+5
Holders Change %
+10.87%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
20
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$534K
2
Millennium Management
Millennium Management
New York
+$325K
3
Goldman Sachs
Goldman Sachs
New York
+$157K
4
BlackRock
BlackRock
New York
+$143K
5
Renaissance Technologies
Renaissance Technologies
New York
+$141K

Top Sellers

Rank Fund Capital Flow
1
CF
Corebridge Financial
Texas
-$28.5K
2
Citigroup
Citigroup
New York
-$20.7K
3
Northern Trust
Northern Trust
Illinois
-$17.6K
4
UBS Group
UBS Group
Switzerland
-$12.8K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$12.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$19.6K -$20.7K -2,173 -50%
NFSG
27
Newbridge Financial Services Group
Florida
$19K +$7.61K +800 +62%
UBS Group
28
UBS Group
Switzerland
$16.7K -$12.8K -1,351 -42%
Raymond James Financial
29
Raymond James Financial
Florida
$6.51K +$6.83K +718 New
Legal & General Group
30
Legal & General Group
United Kingdom
$6K – – –
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$6K -$10.3K -1,087 -63%
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$5.8K +$2.06K +216 +51%
AIP
33
Ameritas Investment Partners
Nebraska
$5.31K – – –
FCMT
34
Founders Capital Management (Texas)
Texas
$4.54K – – –
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$3.93K – – –
Russell Investments Group
36
Russell Investments Group
United Kingdom
$3.52K +$2.09K +220 +131%
BIG
37
Brooklyn Investment Group
New York
$2.21K +$2.32K +244 New
AB
38
Amalgamated Bank
New York
$2K – – –
WTA
39
Washington Trust Advisors
Massachusetts
$1.81K – – –
Carson Wealth (CWM LLC)
40
Carson Wealth (CWM LLC)
Nebraska
$1K +$181 +19 +48%
FDCDDQ
41
Federation des caisses Desjardins du Quebec
Quebec, Canada
$907 – – –
GWM
42
Geneos Wealth Management
Colorado
$798 -$837 -88 -50%
NSIM
43
North Star Investment Management
Illinois
$463 – – –
HFS
44
Hopwood Financial Services
Virginia
$454 – – –
GRP
45
Global Retirement Partners
California
$408 +$428 +45 New
EWA
46
EverSource Wealth Advisors
Alabama
$290 +$276 +29 +967%
SS
47
SBI Securities
Japan
$272 – – –
Nisa Investment Advisors
48
Nisa Investment Advisors
Missouri
$245 -$361 -38 -58%
SCM
49
Sterling Capital Management
North Carolina
$127 +$76 +8 +133%
Jones Financial Companies
50
Jones Financial Companies
Missouri
$90 +$95 +10 New
1
2
3

GLSI Hedge Fund Activity: Q2 2025 in Review

51 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q2 2025, worth a combined $11.2M — up 0.78% from $11.1M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new GLSI positions and 3 closed out — a net gain of 6 holders — while 20 added to existing stakes and 11 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $534K. The largest seller was Corebridge Financial, exiting entirely with an estimated $28.5K sold.

  • 51 institutional investors held Greenwich LifeSciences (GLSI) as of Q2 2025, up from 46 in Q1 2025.
  • Funds reported $11.2M of Greenwich LifeSciences stock for Q2 2025, up 0.78% quarter-over-quarter.
  • 9 funds opened new Greenwich LifeSciences positions in Q2 2025 and 3 closed out, a net change of +6 holders.
  • The largest Greenwich LifeSciences buyer in Q2 2025 was Marshall Wace, an estimated $534K added.
  • The largest Greenwich LifeSciences seller in Q2 2025 was Corebridge Financial, an estimated $28.5K sold.

Based on aggregated 13F filings for Q2 2025.